Universal Ibogaine (IBOGF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 145 214 sessions, October 30, 2025 to October 30, 2026
- Largest daily move
- +1011.1% close of September 22, 2026
- 1-year change
- -98.6% closing prices, October 30, 2025 to October 30, 2026
- 1-month change
- -88.9% closing prices, September 29, 2026 to October 30, 2026
Company Description
Universal Ibogaine (OTC: IBOGF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $31.3K.
IBOGF has declined 98.6% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for IBOGF, including price data, latest news, and short interest trends.
Stock Performance
Universal Ibogaine (IBOGF) closed at $0.0001 on October 30, 2026. Over the past 12 months, the price has lost 98.6%.
IBOGF Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Universal Ibogaine has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all IBOGF news →
SEC Filings
Short Interest History
Short interest in Universal Ibogaine (IBOGF) currently stands at 57.2 thousand shares, representing 0.0% of the float. Since November 2025, short interest has decreased by 43.2%.
Days to Cover History
Days to cover for Universal Ibogaine (IBOGF) currently stands at 2.0 days, up 105% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 105%. Across the settlements charted above, it has ranged from 1.0 to 2.0 days.
IBOGF Company Profile & Sector Positioning
Universal Ibogaine (IBOGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IBOGF often look at related companies in the same sector, including Nascent Biotech Inc (NBIO), Braxia Scientific Corp (BRAXF), Burzynski Resh Institute (BZYR), GB Sciences Inc (GBLX), and Itoco Inc (ITMC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IBOGF's relative position within its industry.